A first month and nothing after it
The header figure is explicitly a first month. No standing rate appears on any page read, and no figure is attached to either compounded drug by name.
Twenty of the one hundred and fifty-eight sellers here put a price beside a product they will only call a GLP-1. This is the sparse version of that: one class-level figure, one term, and nothing else.
A first-month rate with no published successor is the least useful shape a price can take, because the number a reader compares is the only number they will pay once.
The price is on the legal pages, which is the good part
The header renders on the privacy policy as well as the marketing pages. That is worth noting because it means the figure is not gated behind a marketing route or an intake; it is simply the only one there is.
It also means the figure is easy to date and easy to check on a return visit, which is more than can be said for a price that lives inside a plan selector.
Four parties named
The privacy policy names the operating limited liability company. The Terms go further and name the platform provider, two clinical groups, a state professional corporation and the fulfilling pharmacy.
Thirty-two of the one hundred and fifty-eight sellers here name a compounding or dispensing pharmacy at all, and this is one of them. Naming the platform as well as the clinical and pharmacy parties is a fuller disclosure than most.
It is also a reminder of how many companies stand between a buyer and a compounded prescription. No individual clinician is named, no service area is published, and nothing is said about a membership.
Maves's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $99/mostarting at, FIRST MONTH ONLY, from a site-wide header that renders on the privacy policy as well as the marketing pages; no ongoing rate appears on any page read, and no figure is attached to either drug by name | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Maves's current price →Good fit if
- Readers who want to know what a first month costs and will accept that the rest is not published.
- Buyers who want every party in the supply chain named rather than one.
- People who prefer a price that renders on the legal pages to one behind an intake.
Look elsewhere if
- Anyone who needs the ongoing price before starting.
- Buyers comparing drug against drug; the figure names neither.
- Readers who need an individual prescriber named or a service area published.
- People who want to know whether a membership applies.
How this review was verified
- Read the privacy policy on 6 September 2026, where the site-wide price header renders, with a nonsense-path control on the host in the same run that returned a clean not-found status.
- Recorded the figure as a first-month rate because the header says so, and left the ongoing rate unrecorded rather than assuming the same number continues.
- Read the Terms for the parties named and recorded them as published rather than summarising them as partners.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.